[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Normal Guy @Normal_2610 on x 2033 followers
Created: 2025-07-23 10:46:38 UTC
AbbVie deal derisks R&D, front‑loads $XXX m cash, and leaves upside via royalties. Share‑holder payout likely to rise; optionality from India/emerging‑market launches. Long gestation, but asymmetric pay‑off.
XXX engagements
Related Topics $700m $abbv stocks healthcare